469 filings
Page 3 of 24
8-K
kak097iju 42ato9
8 Aug 22
Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results
4:11pm
8-K
oxngml1detpa6t od
10 Jun 22
Departure of Directors or Certain Officers
4:01pm
S-3ASR
ry1q6pcvkmw 4j4xl
25 May 22
Automatic shelf registration
4:07pm
DEFR14A
r2ibjt b1
13 May 22
Revised proxy
5:16pm
8-K
4yo6z9 0d
4 May 22
Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results
4:26pm
CT ORDER
l03a4veduw pob
4 May 22
Confidential treatment order
12:50pm
8-K
n98o3
8 Apr 22
Departure of Directors or Certain Officers
5:26pm
8-K
bs1f4ng7
28 Feb 22
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:12pm
8-K
pp8kzmmw16smq
20 Dec 21
Acadia Pharmaceuticals Announces Plan for a Resubmission of its
9:26pm
8-K
dnw7hmxvhn9
14 Dec 21
Acadia Pharmaceuticals Announces Promotion of Mark Schneyer to Executive Vice
4:52pm
8-K
t455oa 6cysuha
6 Dec 21
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3
5:16pm
8-K
860hyucu6t6ln0dtn
8 Nov 21
Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results
4:15pm
8-K
fafb90mfr uit
5 Nov 21
Acadia Pharmaceuticals Appoints Brendan Teehan, Executive Vice President, Chief Operating Officer, Head of Commercial
4:31pm
8-K
lao 5k2iqm
2 Sep 21
Departure of Directors or Certain Officers
5:00pm
8-K
xwibmhyq0 dnbykp
4 Aug 21
Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:15pm